Dataset of ultralow temperature refrigeration for COVID 19 vaccine distribution solution.

ABSTRACT: Most COVID-19 vaccines require temperature control for transportation and storage. Two types of vaccine have been developed by manufacturers (Pfizer and Moderna). Both vaccines are based on mRNA and lipid nanoparticles requiring low temperature storage. The Pfizer vaccine requires ultra-low temperature storage (-80 °C to -60 °C), while the Moderna vaccine requires -30 °C storage. However, the last stage of distribution is quite challenging, especially for rural or suburban areas, where local towns, pharmacy chains and hospitals may not have the infrastructure required to store the vaccine at the required temperature. In addition, there is limited data available to address ancillary challenges of the distribution framework for both transportation and storage stages, including safety concern

SUBMITTER: Sun J 

PROVIDER: S-EPMC8891306 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature